Three companies that process about 80% of prescriptions in the United States — Caremark, Express Scripts and OptumRx — have ...
In January, a new Idaho law will take effect requiring reform of business practices by pharmacy middlemen — in search of ...
The Federal Trade Commission said Friday that it is suing three drug middlemen, accusing them of inflating insulin prices.
The Federal Trade Commission took action Friday against the nation’s three largest pharmacy benefit managers, accusing the companies of artificially inflating insulin list prices that resulted in ...
Business has been good for the company, which employs about 2,000 people and operates plants in Alabama and overseas. A few ...
For years, pharmacy benefit managers have been the target of ire for politicians ... it wanted that report retracted and was ...
In 2025, everyone enrolled in Part D will have their annual out-of-pocket drug costs capped at $2,000. In future years, that cap will rise in step with the rate of change in Part D costs.